methyl 4-(chlorocarbonothioyloxy)benzoate

We are methyl 4-(chlorocarbonothioyloxy)benzoate CAS:10506-31-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: methyl 4-(chlorocarbonothioyloxy)benzoate
CAS No: 10506-31-7
MF: C9H7ClO3S
MW: 230.66808
Density: N/A
Boiling point: N/A
Melting point: N/A
Flash point: N/A
Refractive index: N/A
UN Number: N/A
UN Proper Shipping Name: N/A
Transport hazard class: N/A
Packing group: N/A
 
Specification
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Organic synthesis intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

methyl 4-(chlorocarbonothioyloxy)benzoate


Related News: Our pharma and biotech offering includes registration and commercialization of products through in-licensing and flexible partnerships.1198396-39-2 This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.1- (sulfamoilamino) propano CAS:147962-41-2 This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.2-chlorophenol According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.

Related Products
Product Name
cyclohexane-1,3-dione View Details
2-(1-Naphthalenyloxy)propanoic acid View Details
(R)-Methyl 2-amino-2-(4-hydroxyphenyl)acetate View Details
4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonyl chloride manufacturer 2-Fluoro-3-nitropyridine manufacturer 5,6-diethyl-2,3-dihydro-1H-inden-2-amine,hydrochloride manufacturer 1,4,7,10-tetraazacyclododecane manufacturer D-Glutamine manufacturer